Accuray (NSDQ:ARAY) shares are down today after the company reported decreased sales and profits in the first quarter of fiscal 2020. The Sunnyvale, Calif.-based radiotherapy device maker posted losses of -$9.4 million, or -11¢ per share, on sales of $89.6 million for the three months ended Sept. 30, for a bottom-line slide of -13% on a […]
Varian gets a jolt from meet-and-beat fiscal numbers, 202 forecast
Varian Medical (NYSE:VAR) got a jolt today from its fiscal fourth-quarter and full-year results, which met the consensus earnings forecast and topped Wall Street’s expectations for sales, and added a pair of names to its senior leadership roster. Palo Alto, Calif.-based radiotherapy device maker posted profits of $89.3 million, or 97¢ per share, on sales of […]
Shine Medical Technologies debuts therapeutics division
Medical isotopes maker Shine Medical Technologies last week created a division to make therapeutic products, saying it plans to first focus on a cancer treatment. The Janesville, Wis.-based company said its Shine Therapeutics business will begin with the development and commercialization of lutetium-177, an isotope that can be combined with a disease-targeting molecule, for treating […]
Isotope maker Shine Medical raises $50m from Oaktree Capital
Shine Medical Technologies said this week that it closed a $50 million financing round from Oaktree Capital Management for the construction of a medical isotope production facility and commercialization of its products. The Janesville, Wis.-based company expects construction on the plant to be completed in 2021, with commercial-scale isotope production slated to begin the following […]
EPMap closes $25m Series A round
Ajax Health announced today that EP Map System GmbH closed a Series A financing round worth $25 million that it plans to use for commercialization of its product line in the U.S. The Herdecke, Germany-based company’s products include a 3D mapping and navigation system with an integrated signal recording and pacing system, a radiofrequency ablation […]
ControlRad drums up $15m Series B round
ControlRad said today that it completed a $15 million Series B round for the commercial launch of its Trace system for reducing radiation in fluoroscopically guided procedures. Norcross, Ga.-based ControlRad’s Trace system is the first FDA-cleared technology that can be integrated into existing mobile C-arms to reduce the ionizing radiation that can occur in FGP. […]
Aurora Concussion Therapy Systems wins breakthrough nod from FDA
Aurora Concussion Therapy Systems said this week that it won breakthrough device designation from the FDA for its Aurora Light therapy system for concussion treatment. The Aurora Light therapy system is designed to apply a non-invasive, near-infrared light to energize the brain’s metabolic cascade process, accelerating the healing process for concussions and other mild brain […]
U.S. exempts more Chinese medtech products from tariffs
The U.S. has exempted another 18 medical devices or device components from the 25% tariffs imposed on Chinese goods by the Trump administration. The new list includes ultrasound, X-ray, MRI and infusion equipment. The Office of the U.S. Trade Representative (USTR) said the new exclusions are retroactive to August 23, 2018, when additional tariffs went […]
ControlRad touts first use for Trace radiation exposure reduction tech
ControlRad today said it completed the first clinical use of its Trace system. Atlanta-based ControlRad’s Trace technology can be integrated into mobile C-arms to help reduce radiation in fluoroscopically guided procedures. The company said it can reduce radiation exposure by up to 89% to protect patients and medical staff without having to compromise image quality […]
Siemens Healthineers wins FDA nod for Artis Icono angiography line
Siemens Healthineers said yesterday that it won FDA clearance for its Artis Icono angiography systems for performing a wide range of minimally invasive procedures in a single interventional suite. The Artis Icono platform includes a biplane system engineered for neuroradiology and abdominal imaging, and a floor-mounted, single-plane system for vascular, interventional cardiology, surgical and oncology […]
Varian backs Oncora, launches Ethos radiotherapy device
Varian Medical (NYSE:VAR) said last week that it invested an unspecified amount in Oncora Medical and launched its Ethos artificial intelligence radiotherapy device. Philadelphia-based Oncora makes software used to plan radiotherapy procedures. Palo Alto, Calif.-based Varian said the partnership with Oncora is aimed at accelerating its software development for radiation oncology. “We envision a world where all […]
- 1
- 2
- 3
- …
- 16
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube